Aspirin is one of the most commonly used nonsteroidal anti-inflammatory drugs. Various potential pharmacological effects of aspirin, such as anticancer, antibacterial activity, and prolonging life expectancy have been discovered. However, the mechanism of aspirin is not fully elucidated. Herein, the effects of aspirin on fatty acid metabolism in yeast cell model Saccharomyces cerevisiae were studied. The results showed that aspirin can induce lipid accumulation and reduce the unsaturated fat index in cells. The assessment of cell membrane integrity demonstrated that aspirin caused damage to the cell membrane. These effects of aspirin were attributed to the alterations of the expression of DCI1 and OLE1. Similarly, aspirin was able to cause lipid accumulation and damage to the cell membrane by interfering with the expression of OLE1 in Candida albicans. These findings are expected to improve current understanding of the mode of action of aspirin and provide a novel strategy for antifungal drug design.
Graphical abstract
Get full access to this article
View all access options for this article.
References
1.
AwtryE.H., and LoscalzoJ.. 2000. Aspirin. Circulation, 101:1206–1218.
2.
CryerB., and FeldmanM.. 1999. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology, 117:17–25.
3.
LangleyR.E., and RothwellP.M.. 2013. Biological markers: potential biomarker for aspirin use in colorectal cancer therapy. Nat. Rev. Clin. Oncol. 10:8.
4.
Martin, S.J. 2007. Antimicrobial stewardship: the aspirin of the 21st Century. Expert Rev. Anti-Infect. 5:159–161.
5.
KeserD., and KarataşA.. 2012. Effects of aspirin and acetaldehtde on longevity and metamorphosis duration of drosophila melanogaster. Fresen. Environ. Bull. 21:2758–2765.
6.
AlemM.A.S., and DouglasL.J.. 2004. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemother. 48:41–47.
7.
SapienzaK., and BalzanR.. 2005. Metabolic aspects of aspirin-induced apoptosis in yeast. FEMS Yeast Res. 5:1207–1213.
8.
FarrugiaG., BannisterW.H, VassalloN., and BalzanR.. 2013. Aspirin-induced apoptosis of yeast cells is associated with mitochondrial superoxide radical accumulation and NAD (P) H oxidation. FEMS Yeast Res. 13:755–768.
9.
BotsteinD., and FinkG.R.. 2011. Yeast: an experimental organism for 21st Century biology. Genetics, 189:695–704.
10.
Arlia-CiommoA., PianoA., LeonovA., SvistkovaV., and TitorenkoV.I.. 2014. Quasi-programmed aging of budding yeast: a trade-off between programmed processes of cell proliferation, differentiation, stress response, survival and death defines yeast lifespan. Cell Cycle, 13:3336–3349.
11.
FontanaL., PartridgeL., and LongoV.D.. 2010. Extending healthy life span—from yeast to humans. Science, 328:321–326.
12.
Kohlwein, S.D. 2010. Obese and anorexic yeasts: experimental models to understand the metabolic syndrome and lipotoxicity. BBA-Mol. Cell Biol. 1801:222–229.
13.
Menacho-MarquezM., and MurguiaJ.R.. 2007. Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research. Clin. Transl. Oncol. 9:221–228.
14.
BirrellG.W., GuriG., ChuA.M, DavisR.W, and BrownJ.M. 2001. genome-wide screen inA. Saccharomyces cerevisiae. for genes affecting UV radiation sensitivity. Proc. Natl. Acad. Sci. U.S.A. 98: 12608–1, 2613.
LumP.Y., ArmourC.D, StepaniantsS.B, CavetG., WolfM.K, ButlerJ.S, HinshawJ.C, GarnierP., PrestwichG.D, LeonardsonA., Garrett-EngeleP., RushC.M, BardM., SchimmackG., PhillipsJ.W, RobertsC.J, and ShoemakerD.D.. 2004. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell, 116:121–137.
17.
MartonM.J., DeRisiJ.L, BennettH.A, IyerV.R, MeyerM.R, RobertsC.J, StoughtonR., BurchardJ., SladeD., DaiH., Bassett JrD.E., HartwellL.H, BrownP.O, and FriendS.H.. 1998. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4:1293.
18.
NatterK., LeitnerP., FaschingerA., WolinskiH., McCraitS., FieldsS., and KohlweinS.D.. 2005. The spatial organization of lipid synthesis in the yeast Saccharomyces cerevisiae derived from large scale green fluorescent protein tagging and high resolution microscopy. Mol. Cell. Proteom. 4:662–672.
19.
GeisbrechtB.V., SchulzK., NauK., GeraghtyM.T, SchulzH., ErdmannR., and GouldS.J.. 1999. Preliminary characterization of Yor180Cp: identification of a novel peroxisomal protein of Saccharomyces cerevisiae involved in fatty acid metabolism.” Biochem. Biophys. Res. Commun. 260:28–34.
20.
OgasawaraY., KiraS., MukaiY., NodaT. and YamamotoA.. 2017. Ole1, fatty acid desaturase, is required for Atg9 delivery and isolation membrane expansion during autophagy in Saccharomyces cerevisiae. Biol. Open, 6:35–40.
21.
PanX., YuanD.S, OoiS.-L, WangX., Sookhai-MahadeoS., MeluhP., and BoekeJ.D.. 2007. dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiae. Methods, 41:206–221.
22.
PanX., D.S.Yuan, XiangD., WangX., Sookhai-MahadeoS., BaderJ.S, HieterP., SpencerF., and BoekeJ.D.. 2004. A robust toolkit for functional profiling of the yeast genome. Mol. Cell, 16:487–496.
23.
AdeyoO., HornP.J, LeeS., BinnsD.D, ChandrahasA., ChapmanK.D, and GoodmanJ.M.. 2011. The yeast lipin orthologue Pah1p is important for biogenesis of lipid droplets. J. Cell Biol. 192:1043–1055.
24.
SchneiterR., and DaumG.. 2006. Extraction of yeast lipids. Methods Mol. Biol. 313:41–45.
25.
LiuD., ZengX.A, SunD.W, and HanZ.. 2013. Disruption and protein release by ultrasonication of yeast cells. Innov. Food Sci. Emerg. 18:132–137.
26.
WangS., WangJ., ZhangX., HuL., FangZ., HuangZ., and ShiP.. 2016. Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis. Biometals, 29:881–892.
27.
MalikM.A., Al-ThabaitiS.A, and MalikM.A.. 2012. Synthesis, structure optimization and antifungal screening of novel tetrazole ring bearing acyl-hydrazones. Int. J. Mol. Sci. 13:10880–10898.
28.
ChellappaR., KandasamyP., OhC.S, JiangY., VemulaM., and MartinC.E.. 2001. The membrane proteins, Spt23p and Mga2p, play distinct roles in the activation of Saccharomyces cerevisiae OLE1 gene expression fatty acid-mediated regulation of Mga2p activity is independent of its proteolytic processing into a soluble transcription activator. J. Biol. Chem. 276:43548–43556.
29.
YoshidaY., WangS., and OsameM.. 1998. Aspirin induces short-chain free fatty acid accumulation in rats. Eur. J. Pharmacol. 349:49–52.
30.
GurvitzA., MursulaA.M, YagiA.I, HartigA., RuisH., RottensteinerH., and HiltunenJ.K.. 1999. Alternatives to the isomerase-dependent pathway for the β-oxidation of oleic acid are dispensable in Saccharomyces cerevisiae identification of Yor180c/DCI1 encoding peroxisomal Δ3, 5-Δ2, 4-dienoyl -CoA isomerase. J. Biol. Chem. 274:24514–24521.
31.
Van der RestM.E., KammingaA.H, NakanoA., AnrakuY., PoolmanB., and KoningsW.N.. 1995. The plasma membrane of Saccharomyces cerevisiae: structure, function, and biogenesis. Microbiol. Rev. 59:304–322.
32.
FerreiraR., TeixeiraP.G, SiewersV., and NielsenJ.. 2018. Redirection of lipid flux toward phospholipids in yeast increases fatty acid turnover and secretion. Proc. Natl. Acad. Sci. U.S.A. 115:1262–1267.
33.
FangZ., ChenZ., WangS., ShiP., ShenY., ZhangY., XiaoJ., and HuangZ.. 2017. Overexpression of OLE1 enhances cytoplasmic membrane stability and confers resistance to cadmium in Saccharomyces cerevisiae. Appl. Environ. Microb. 83:e02319-16.
34.
OhC.S., and MartinC.E.. 2006. Candida albicans Spt23p controls the expression of the Ole1p Δ9 fatty acid desaturase and regulates unsaturated fatty acid biosynthesis. J. Biol. Chem. 281:7030–7039.
35.
HawleyS.A., FullertonM.D, RossF.A, SchertzerJ.D, ChevtzoffC., WalkerK.J, PeggieM.W, ZibrovaD., GreenK.A, MustardK.J, KempB.E, SakamotoK., SteinbergG.R, and HardieD.G.. 2012. The ancient drug salicylate directly activates AMP-activated protein kinase. Science, 336:918–922.
GlasgowaJ.F., MiddletonbB., MooreaR., GrayaA., and HillJ.. 1999. The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. BBA-Mol. Basis Dis. 1454:115–125.
40.
GlasgowJ.FT., and MiddletonB.. 2001. Reye syndrome—insights on causation and prognosis. Arch. Dis. Child. 85:351–353.
41.
LiX.C., JoshiA.S, ElSohlyH.N, KhanS.I, JacobM.R, ZhangZ., KhanI.A, FerreiraD., WalkerL.A, Broedel JrS.E, RaulliR.E, and CihlarR.L.. 2002. Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies. J. Nat. Prod. 65:1909–1914.
42.
PanZ., CamaraB., GardnerH.W, and BackhausR.A.. 1998. Aspirin inhibition and acetylation of the plant cytochrome P450, allene oxide synthase, resembles that of animal prostaglandin endoperoxide H synthase. J. Biol. Chem. 273:18139–18145.
43.
HeZ., PengY., DuanW., TianY., ZhangJ., HuT., CaiY., FengY., and LiG.. 2015. Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway. J. Toxicol. Sci. 40:127–136.
LiuS., RuanW., LiJ., XuH., WangJ., GaoY., and WangJ.. 2008. Biological control of phytopathogenic fungi by fatty acids. Mycopathologia, 166:93–102.
46.
NtambiJ.M., and BeneH.. 2001. Polyunsaturated fatty acid regulation of gene expression. J. Mol. Neurosci. 16:273–278.
47.
LitmanB.J., NiuS.L, PolozovaA., and MitchellD.C.. 2001. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J. Mol. Neurosci. 16:237–242.
48.
YouK.M., RosenfieldC.L, and KnippleD.C.. 2003. Ethanol tolerance in the yeast Saccharomyces cerevisiae is dependent on cellular oleic acid content. Appl. Environ. Microbiol. 69:1499–1503.
49.
RupčićJ., and G.Č. Jurešić. 2010. Influence of stressful fermentation conditions on neutral lipids of a Saccharomyces cerevisiae brewing strain. World J. Microb. Biotechnol. 26:1331–1336.
50.
ChoiS.S., ParkS.H, SimY.B, and SuhH.W.. 2012. Effect of decursinol on the aspirin-induced gastric ulcer in mice. J. Korean Soc. Appl. Biol. Chem. 55:343–345.
51.
NkuC.O., OghaleG.O, and AjiwhenI.O.. 2015. Locomotor behaviour and anxiety in the open field and light/dark box in CD1 mice treated with aspirin, cataflam and ethanolic extract of cannabis sativa. Br. J. Med. Med. Res. 6:563.
52.
BossieM.A., and MartinC.E.. 1989. Nutritional regulation of yeast delta-9 fatty acid desaturase activity. J. Bacteriol. 171:6409–6413.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
